Stay up to date on the latest news and tweets of the Pereira Lab!

Spin-off From Pereira Lab Raises 6M Euros to Advance In vivo DC Reprogramming

Asgard Therapeutics AB, a private biotech company spin off from the Pereira Lab, announces the completion of a EUR 6 million seed financing round. The financing was co-led by Novo Holdings, Boehringer Ingelheim Venture Fund and Industrifonden.

Fábio Rosa Defended His PhD Thesis

On June 10th 2021, Fábio Rosa defended his thesis “Generating Dendritic Cells by Direct Cell Reprogramming. Merging cellular reprogramming with immunology towards the development of novel cancer immunotherapies.” with Prof. Thomas Graf from the Center for Genomic Regulation (Spain) as opponent.

Filipe Pereira Is The New Editor-in-Chief of Cellular Reprogramming

Following on the legacy of Professor Sir Ian Wilmut, Filipe Pereira becomes the new Editor-in-Chief of the Cellular Reprogramming Journal.

Filipe Pereira Awarded a Swedish Research Council Consolidator Grant

The Swedish Research Council (Vetenskapsrådet) has published the results for this year’s applications for consolidator grants, in which Filipe Pereira was selected for, in the scientific area of Medicine and health.

Luís Oliveira Awarded a PhD Studentship From The Foundation for Science and Technology

Pereira Lab researcher Luís Oliveira was awarded a fully funded 4 year scholarship by the Portuguese Foundation for Science and Technology (FCT) to develop his PhD-leading research.

Pereira Lab Funded by the Mats Paulsson Foundation

The Pereira Lab has been awarded a grant from the Mats Paulsson Foundation for Research, Innovation and Societal Development on a project aiming at Harnessing Dendritic Cell Reprogramming for Cancer Immunotherapy.

Filipe Pereira Awarded the KiiLNYC Postdoc Entrepreneurship Award

Filipe Pereira was recently awarded with the KiiLN Postdoctoral Entrepreneurship Award by the Keystone for Incubating Innovation in Life Sciences Network at the Icahn School of Medicine Innovation Awards.

Olga Zimmermannova Awarded a Grant From the Royal Physiographic Society of Lund

Pereira Lab Cancerfonden postdoctoral fellow Olga Zimmermannova was awarded a grant from the Royal Physiographic Society of Lund, one of the Royal Academies promoting scientific progress in Sweden.

Pereira Lab Awarded Funding From the Swedish Cancer Society and the Portuguese Foundation for Science and Technology

The project entitled “Understanding dendritic cell diversity with cell reprogramming” aims at a better comprehension of dendritic cell development, with interesting new possibilities in cancer immunotherapy.

Prestigious ERC consolidator grant for innovative immunotherapy research at the Pereira Lab

Filipe Pereira was today announced as one of the 89 selected researchers by the European Research Council of its latest Consolidator Grant competition. He will be awarded an ERC Consolidator Grant of 2 million EUR over a period of five years. The project will merge the cell reprogramming and cancer immunotherapy fields to develop innovative therapeutic strategies.